EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
170 hedge funds and large institutions have $853M invested in Eagle Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 55 increasing their positions, 58 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+1
Holders Change %
+0.59%
% of All Funds
3.86%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
28
Increased
55
Reduced
58
Closed
25
Calls
$5.53M
Puts
$5.04M
Net Calls
+$493K
Net Calls Change
-$1.33M
Top Buyers
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$27M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$9.62M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$6.84M |
| 4 |
PP
PDT Partners
New York
|
+$5.65M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$4.67M |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$11.9M |
| 2 |
State Street
Boston,
Massachusetts
|
-$11.1M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$7.82M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$7.75M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$6.67M |
